NM_133379.5:c.11196G>C

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_133379.5(TTN):​c.11196G>C​(p.Leu3732Phe) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.996 in 1,609,690 control chromosomes in the GnomAD database, including 797,963 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/14 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.98 ( 72577 hom., cov: 32)
Exomes 𝑓: 1.0 ( 725386 hom. )

Consequence

TTN
NM_133379.5 missense

Scores

14

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: -0.174
Variant links:
Genes affected
TTN (HGNC:12403): (titin) This gene encodes a large abundant protein of striated muscle. The product of this gene is divided into two regions, a N-terminal I-band and a C-terminal A-band. The I-band, which is the elastic part of the molecule, contains two regions of tandem immunoglobulin domains on either side of a PEVK region that is rich in proline, glutamate, valine and lysine. The A-band, which is thought to act as a protein-ruler, contains a mixture of immunoglobulin and fibronectin repeats, and possesses kinase activity. An N-terminal Z-disc region and a C-terminal M-line region bind to the Z-line and M-line of the sarcomere, respectively, so that a single titin molecule spans half the length of a sarcomere. Titin also contains binding sites for muscle associated proteins so it serves as an adhesion template for the assembly of contractile machinery in muscle cells. It has also been identified as a structural protein for chromosomes. Alternative splicing of this gene results in multiple transcript variants. Considerable variability exists in the I-band, the M-line and the Z-disc regions of titin. Variability in the I-band region contributes to the differences in elasticity of different titin isoforms and, therefore, to the differences in elasticity of different muscle types. Mutations in this gene are associated with familial hypertrophic cardiomyopathy 9, and autoantibodies to titin are produced in patients with the autoimmune disease scleroderma. [provided by RefSeq, Feb 2012]
TTN-AS1 (HGNC:44124): (TTN antisense RNA 1) This gene encodes a non-coding RNA transcribed from the opposite strand to the titin gene. [provided by RefSeq, Aug 2016]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=8.2521825E-7).
BP6
Variant 2-178751204-C-G is Benign according to our data. Variant chr2-178751204-C-G is described in ClinVar as [Benign]. Clinvar id is 47735.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-178751204-C-G is described in Lovd as [Benign].
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.993 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TTNNM_133379.5 linkc.11196G>C p.Leu3732Phe missense_variant Exon 46 of 46 ENST00000360870.10 NP_596870.2 Q8WZ42-6Q7Z3B7
TTNNM_001267550.2 linkc.11311+1920G>C intron_variant Intron 47 of 362 ENST00000589042.5 NP_001254479.2 A0A0A0MTS7

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TTNENST00000360870.10 linkc.11196G>C p.Leu3732Phe missense_variant Exon 46 of 46 5 NM_133379.5 ENSP00000354117.4 Q8WZ42-6
TTNENST00000589042.5 linkc.11311+1920G>C intron_variant Intron 47 of 362 5 NM_001267550.2 ENSP00000467141.1 A0A0A0MTS7

Frequencies

GnomAD3 genomes
AF:
0.977
AC:
148363
AN:
151920
Hom.:
72550
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.918
Gnomad AMI
AF:
1.00
Gnomad AMR
AF:
0.994
Gnomad ASJ
AF:
1.00
Gnomad EAS
AF:
1.00
Gnomad SAS
AF:
1.00
Gnomad FIN
AF:
1.00
Gnomad MID
AF:
0.994
Gnomad NFE
AF:
1.00
Gnomad OTH
AF:
0.981
GnomAD3 exomes
AF:
0.994
AC:
245536
AN:
246976
Hom.:
122088
AF XY:
0.996
AC XY:
132891
AN XY:
133470
show subpopulations
Gnomad AFR exome
AF:
0.920
Gnomad AMR exome
AF:
0.997
Gnomad ASJ exome
AF:
1.00
Gnomad EAS exome
AF:
1.00
Gnomad SAS exome
AF:
1.00
Gnomad FIN exome
AF:
1.00
Gnomad NFE exome
AF:
1.00
Gnomad OTH exome
AF:
0.997
GnomAD4 exome
AF:
0.998
AC:
1454075
AN:
1457652
Hom.:
725386
Cov.:
48
AF XY:
0.998
AC XY:
723135
AN XY:
724640
show subpopulations
Gnomad4 AFR exome
AF:
0.912
Gnomad4 AMR exome
AF:
0.996
Gnomad4 ASJ exome
AF:
1.00
Gnomad4 EAS exome
AF:
1.00
Gnomad4 SAS exome
AF:
1.00
Gnomad4 FIN exome
AF:
1.00
Gnomad4 NFE exome
AF:
1.00
Gnomad4 OTH exome
AF:
0.994
GnomAD4 genome
AF:
0.976
AC:
148446
AN:
152038
Hom.:
72577
Cov.:
32
AF XY:
0.977
AC XY:
72655
AN XY:
74328
show subpopulations
Gnomad4 AFR
AF:
0.917
Gnomad4 AMR
AF:
0.994
Gnomad4 ASJ
AF:
1.00
Gnomad4 EAS
AF:
1.00
Gnomad4 SAS
AF:
1.00
Gnomad4 FIN
AF:
1.00
Gnomad4 NFE
AF:
1.00
Gnomad4 OTH
AF:
0.981
Alfa
AF:
0.977
Hom.:
54328
Bravo
AF:
0.973
TwinsUK
AF:
1.00
AC:
3708
ALSPAC
AF:
1.00
AC:
3854
ESP6500AA
AF:
0.920
AC:
4053
ESP6500EA
AF:
0.999
AC:
8585
ExAC
AF:
0.993
AC:
120419
Asia WGS
AF:
0.992
AC:
3451
AN:
3478
EpiCase
AF:
1.00
EpiControl
AF:
1.00

ClinVar

Significance: Benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:5
Jan 21, 2014
GeneDx
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

Sep 16, 2011
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Jun 24, 2013
Biesecker Lab/Clinical Genomics Section, National Institutes of Health
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: research

- -

-
Clinical Genetics, Academic Medical Center
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Benign
-0.68
T
BayesDel_noAF
Benign
-0.68
CADD
Benign
6.1
DANN
Benign
0.96
Eigen
Benign
-0.63
Eigen_PC
Benign
-0.54
FATHMM_MKL
Benign
0.089
N
LIST_S2
Benign
0.40
T
MetaRNN
Benign
8.3e-7
T
MetaSVM
Benign
-0.97
T
PROVEAN
Benign
-0.12
N
REVEL
Benign
0.14
Sift
Benign
0.10
T
Sift4G
Benign
0.70
T
Polyphen
0.0030
B
Vest4
0.028
MutPred
0.26
Loss of stability (P = 0.0961);
ClinPred
0.0017
T
GERP RS
3.9

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs922985; hg19: chr2-179615931; COSMIC: COSV59896745; COSMIC: COSV59896745; API